Skip to main content

Table 4 Bivariate analysis of factors influencing HADS-Anxiety

From: The correlation of anxiety and depression with C3 and C4 Levels and systemic lupus erythematosus activity

VARIABLE

HADS Anxiety

P Value

Age (correlation)

-0,059

0,522

Steroid duration, correlation

-0,153

0,095

C3 levels, correlation

0,189

0,038

C4 levels, correlation

-0,185

0,043

Mex-SLEDAI

0,173

0,06

Marital Status, median (IQR)

 Unmarried

5 (4,5)

0,220

 Married

6 (5)

 Divorced

8,5 (12,5)

Organ Involvement,

 Mucocutaneous, median (IQR)

 

0,763

  Yes

5 (4)

 

  No

5 (7,25)

 

 Musculoskeletal, median (IQR)

 

0,21

  Yes

5 (4,25)

 

  No

7,5 (7,5)

 

 Hematology, median (IQR)

 

0,973

  Yes

6 (4,25)

 

  No

5 (5)

 

 Kidney, median (IQR)

 

0,45

  Yes

5 (4)

 

  No

5 (5)

 

 Serositis, median (IQR)

 

0,08

  Yes

6 (4,5)

 

  No

5 (5)

 

DMARD

 Azathioprine, median (IQR)

 

0,055

  Yes

4 (3)

 

  No

6 (5)

 

 Cyclosporine, median (IQR)

 

0,558

  Yes

6 (2)

 

  No

5 (4)

 

 HCQ, median (IQR)

 

0,838

  Yes

5 (4)

 

  No

5 (5,5)

 

 Mycophenolate, median (IQR)

 

0,531

  Yes

5 (5)

 

  No

5 (4,25)

 
  1. C3 complement 3, C4 complement 4, DMARD Disease-Modifying Antirheumatic Drugs, HADS A Hospital Anxiety and Depression Scale for anxiety, HADS-D Hospital Anxiety and Depression Scale for depression, HCQ Hydroxychloroquine, Mex SLEDAI Mexican systemic lupus erythematosus systemic disease activity